Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 116,505 | 96,185 | 68,855 | 30,621 | 124,664 |
| Depreciation Amortization | 22,193 | 16,532 | 11,048 | 5,490 | 22,509 |
| Income taxes - deferred | -2,970 | -2,603 | -5,775 | 2,968 | -2,423 |
| Accounts payable and accrued liabilities | -4,572 | -4,223 | -5,030 | -6,899 | 6,076 |
| Other Working Capital | -33,060 | -24,893 | -22,941 | -23,207 | 556 |
| Other Operating Activity | 23,131 | 15,307 | 12,660 | 10,686 | 9,019 |
| Operating Cash Flow | $121,227 | $96,305 | $58,817 | $19,659 | $160,401 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,748 | -9,595 | -3,131 | -1,584 | -15,088 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -20,000 |
| Other Investing Activity | -1,439 | -1,439 | -1,451 | -1,504 | 1,127 |
| Investing Cash Flow | $-14,187 | $-11,034 | $-4,582 | $-3,088 | $-33,961 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | N/A | N/A | 60,000 |
| Common Stock Repurchased | -177,837 | -145,926 | -99,155 | -67,610 | -57,029 |
| Other Financing Activity | -3,575 | -3,041 | -2,981 | -2,865 | -62,413 |
| Financing Cash Flow | $-181,412 | $-148,967 | $-102,136 | $-70,475 | $-59,442 |
| Exchange Rate Effect | 2,088 | -351 | 515 | -1,962 | 11,251 |
| Beginning Cash Position | 315,937 | 315,937 | 315,937 | 315,937 | 237,688 |
| End Cash Position | 243,653 | 251,890 | 268,551 | 260,071 | 315,937 |
| Net Cash Flow | $-72,284 | $-64,047 | $-47,386 | $-55,866 | $78,249 |
| Free Cash Flow | |||||
| Operating Cash Flow | 121,227 | 96,305 | 58,817 | 19,659 | 160,401 |
| Capital Expenditure | -12,763 | -9,610 | -3,146 | -1,597 | -15,094 |
| Free Cash Flow | 108,464 | 86,695 | 55,671 | 18,062 | 145,307 |